President-elect Donald Trump hosted a dinner at Mar-a-Lago with Robert F. Kennedy Jr. and top pharmaceutical leaders, including Pfizer CEO Albert Bourla, Eli Lilly CEO David Ricks, and PhRMA head Steve Ubl. The gathering focused on cancer research and reforming healthcare through public-private partnerships.
Kennedy, selected to lead the Department of Health and Human Services, has long voiced concerns about the unchecked influence of pharmaceutical companies. His attendance signals the administration’s intent to scrutinize the industry while exploring opportunities for collaboration.
Elizabeth McDonald asks Dr. Peter McCullough
"What do you make of this, so Pfizer, Eli Lilly, big pharma execs go to Mar a Lago try to lobby Trump to ease up on them on the make America healthy again push but Trump brought RFK Jr. to the meeting what do you think of all this?"… pic.twitter.com/iy8dBSUU5f
— DrRay (@DrNoMask) December 7, 2024
Trump’s healthcare agenda prioritizes lowering drug costs and ensuring fairness for Americans, aligning with Kennedy’s advocacy for more accountability within the pharmaceutical sector. The meeting highlights the administration’s dual strategy of fostering innovation and addressing corporate practices that have raised public concerns.
The pharmaceutical industry has faced heightened criticism following legislation granting Medicare the authority to negotiate drug prices. Trump’s engagement with industry leaders and Kennedy reflects an effort to balance reform with support for medical advancements..
Big Pharma Eli Lilly Announces $3B Manufacturing Expansion in Kenosha Following Strategic Meeting with Trump and RFK Jr. at Mar-a-Lago | The Gateway Pundit
Kenosha, Wisconsin, is poised for an economic revival, thanks to a groundbreaking $3 billion investment from pharmaceutical… pic.twitter.com/tqwc6e53x6
— Owen Gregorian (@OwenGregorian) December 8, 2024
Also present was Dr. Mehmet Oz, Trump’s nominee to oversee Medicare and Medicaid. The conversations, which reportedly lasted several hours, focused on how government and industry can work together to tackle healthcare challenges.
🚨Big Pharma Eli Lilly Announces $3B Manufacturing Expansion in Kenosha Following Strategic Meeting with President Trump and RFK Jr. at Mar-a-Lago
— Tiffany Hudson (@Patriot_NiNi) December 7, 2024
This dinner underscores Trump’s vision for healthcare reform, combining the expertise of industry leaders with Kennedy’s critical perspective to protect public health while fostering innovation.
